In Brief: Procter & Gamble Alora
Executive Summary
Procter & Gamble Alora: Theratech-developed transdermal estradiol patch approved Dec. 20 for vasomotor symptoms of menopause. Alora is classified "3S," denoting new formulation given a standard review. Alora is licensed to P&G worldwide, except in Asia. TheraTech will manufacture the patch in Salt Lake City ("The Pink Sheet" Jan. 1, In Brief)...